Offerings Archives - Page 19 of 166

1 minute read

Phunware Announces Pricing Of $10M Public Offering Of 40M Shares Of Common Stock At A Price Of $0.25/Share

February 7, 10:10 AM

Phunware, Inc. (NASDAQ:PHUN, "Phunware")))), the pioneer of patented Location Based SaaS solutions and other products that offer the only fully integrated enterprise cloud platform for mobile that enables brands to

PHUN

2 minute read

Rekor Systems Announces Pricing Of Follow-On Public Offering Of 10M Shares Of Common Stock At A Price Of $2.50/Share

By Benzinga Newsdesk

February 7, 9:42 AM

Rekor Systems, Inc. (NASDAQ:REKR) ("Rekor" or the "Company"), a leader in developing and implementing state-of-the-art roadway intelligence technology, today announced the pricing of its underwritten public offering of

REKR

1 minute read

Clearside Biomedical Announces Pricing Of $15M Registered Direct Offering With Institutional Investors And An Existing Stockholder, Providing For The Purchase And Sale Of 11,111,111 Shares Of Common Stock And Accompanying Warrant

By Benzinga Newsdesk

February 7, 9:23 AM

Clearside Biomedical, Inc. ("Clearside" or the "Company") (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®),

CLSD

4 minute read

Vaccinex Announces Pricing Of $3.7M Private Placement For The Sale Of An Aggregate 3,838,544 Shares Of Common Stock

By Benzinga Newsdesk

February 7, 9:08 AM

accinex, Inc. (NASDAQ:VCNX) ("Vaccinex" or the "Company"), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative disease by blocking astrogliosis and neuroinflammation

VCNX

1 minute read

MeridianLink Announces Pricing of $131.2M Secondary Offering of 6.9M Shares by Certain Selling Stockholders and Related Common Stock Repurchase at $19/Share

By Benzinga Newsdesk

February 7, 6:36 AM

MeridianLink, Inc. (the "Company") (NYSE:MLNK), a leading provider of modern software platforms for financial institutions and consumer reporting agencies, today announced the pricing of the previously

MLNK

2 minute read

Former WeWork CEO Adam Neumann Wants To Buy His Old Company Back With A Hedge Funder’s Support

By Piero Cingari

February 6, 10:40 AM

Controversial co-founder Adam Neumann, with Third Point, bids to acquire bankrupt WeWork, revealing its financial struggles and exit package.

WEWKQ

2 minute read

Former WeWork CEO Adam Neumann Aims To Buy Bankrupt Company With Third Point’s Backing

By Piero Cingari

February 6, 10:28 AM

Controversial co-founder Adam Neumann, with Third Point, bids to acquire bankrupt WeWork, revealing its financial struggles and exit package.

WEWKQ

2 minute read

Lineage Cell Therapeutics Announces $14M Million Registered Direct Offering

By Benzinga Newsdesk

February 6, 10:17 AM

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that it entered into a definitive

LCTX

1 minute read

Jasper Therapeutics Announces Pricing Of $50M Underwritten Offering Of 3.9M Shares Of Common Stock At A Price Of $12.95/Share

By Benzinga Newsdesk

February 6, 10:01 AM

Jasper Therapeutics, Inc. (NASDAQ:JSPR) ("Jasper"), a clinical-stage biotechnology company focused on developing novel antibody therapies targeting c-Kit (CD117) to address diseases such as chronic spontaneous urticaria

JSPR

2 minute read

BioRestorative Therapies Announces Exercise Of Warrants And Issuance Of New Warrants In A Private Placement For $8.1M Gross Proceeds Priced At-The-Market

By Benzinga Newsdesk

February 6, 9:09 AM

BioRestorative Therapies, Inc. ("BioRestorative" or the "Company") (NASDAQ:BRTX), a clinical stage company focused on stem cell-based therapies, today announced it has entered into agreements with certain holders of its

BRTX